GL1X · GenesisL1 explorer

Research workbench

RUTHENIUM(II)(CYMENE)(CHLORIDO)2-lysozyme adduct formed when RUTHENIUM(II)(CYMENE)(BROMIDO)2 underwent ligand exchange, resulting in one binding site

Analyse RUTHENIUM(II)(CYMENE)(CHLORIDO)2-lysozyme adduct formed when… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5V4H
Type
protein
Length
129 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme C
EC
3.2.1.17
UniProt
P00698
Ligands
RU7, NA
Pockets
1 · best druggability 0.30

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme C (EC 3.2.1.17)protein12941% helix, 11% strandP00698

Ligands and binding sites

  • RU7 · Para-cymene ruthenium chloride · ligand · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.300.7417empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5V4H · Ruthenium(II)(cymene)(chlorido)2-lysozyme adduct formed when… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.